Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.
about
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001Calibration of multiple poliovirus molecular clocks covering an extended evolutionary rangeCirculation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence.Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.Estimating the extent of vaccine-derived poliovirus infection.Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 geneApplication of a molecular panel to demonstrate enterotropic virus shedding by healthy and human immunodeficiency virus-infected patients.Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.Frequency and dynamics of recombination within different species of human enteroviruses.Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological propertiesModulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.Evolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall.Characteristics of an environmentally monitored prolonged type 2 vaccine derived poliovirus shedding episode that stopped without interventionSequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiencyRecombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediatesUse of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.Polio eradication, cessation of vaccination and re-emergence of disease.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008.Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaChanges in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patientA Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine PoliovirusS2M: A Stochastic Simulation Model of Poliovirus Genetic State Transition.Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the futureTransmission networks and population turnover of echovirus 30Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.
P2860
Q24559785-603081D1-629D-4843-85D7-387B68F03314Q24655520-BB23C506-9A57-4306-AB38-25C31ED1E2CBQ24682487-F1B89E5E-1AA8-416C-8106-2CF15FED7C6EQ31034162-EE6F0F48-8828-4C7E-A2B8-A15CD5AEA2CDQ33310740-A0FF7A52-BA05-488C-B5A1-CB25FF2C49FAQ33346729-829CD6F2-01E5-4312-A8A7-8E4613AF195DQ33380220-1EA77BE9-A1E1-4BCE-8AC6-61E14C181920Q33725572-5FBB47B9-8804-4FC1-BCEB-45FEBAFBB72CQ33753411-1EC00538-C38B-4D35-881A-3EE34F656333Q33809550-E36B4D2C-6EE2-4D27-AF06-32D8C7328D1BQ33826952-1ABCAF24-9E40-47DE-BAE3-449678ABC5DEQ33930329-7381AA43-1191-4AAA-B3A5-B0B13B556A62Q33969974-986A6C44-AB6D-4333-8EF8-810C65E70361Q34045658-47FE6709-10D8-42AC-BBD3-4D65E8439DC1Q34232997-85AE8296-2FDF-4A54-A4DF-9EF7C52C88BCQ34341696-7B362170-5521-4FCC-9352-4451A8F0739FQ34365810-C7AFD636-CEE2-4BE0-95C9-2AD9CF5E7FDEQ34435032-4AEF4A92-E64E-4393-9216-B1AFB1FE49BDQ34545765-1D6149B6-43B9-498C-A565-5E9A5527692DQ34772540-44351D67-F7A3-4753-A481-D6951E6930ACQ34806015-AC54B37C-DCBC-43F5-8777-CC6D71A21254Q34917653-E1E67DF4-2EF5-4717-9AC1-4B74977F5BAEQ35035879-1BDC889B-82AE-481F-B582-84D70480DC1AQ35190954-A866CBF7-4BB1-4A7D-BA87-70B589CE0E46Q35220868-4B7161F1-53AC-4D1E-A97F-31DD0A786BC2Q35757398-6401F614-85AE-4D82-8A28-54B2BFE73D89Q35777670-08C1828A-3872-4001-9B33-C5878959B74AQ35779733-32F04700-7ED1-408A-9336-7D2D214FF068Q35877053-0789D191-EB0F-4E85-A102-2AA74B65319DQ35979972-EDBBB431-610A-46F5-B7D4-BB64ACF8379EQ36049019-88C3F99E-71E0-44E7-839F-A183A8FC34E5Q36362236-142B0BA6-DB4F-4E24-B608-2DE1C8782A1FQ36424135-376FC330-14A4-4850-9D68-4DD99D4B6F99Q36760045-334DBC57-7691-43F6-A277-696654C47628Q36898727-409B1C33-C7EC-462F-850B-A29CFD052682Q37002529-DBAE3A3A-F7C7-43F3-B228-CC909289799EQ37047006-26B94079-7543-4E38-AC50-502F6D632F0FQ37060273-75AF227F-5CF6-4E82-B7BC-ED50E2E5F254Q37099683-1195E812-9E4D-4A5F-8EE3-7D3756EE6C4AQ37336380-CA69B713-0FFB-4C44-A9E2-2225DA779CC7
P2860
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evolution of the Sabin strain ...... day period of virus excretion.
@ast
Evolution of the Sabin strain ...... day period of virus excretion.
@en
type
label
Evolution of the Sabin strain ...... day period of virus excretion.
@ast
Evolution of the Sabin strain ...... day period of virus excretion.
@en
prefLabel
Evolution of the Sabin strain ...... day period of virus excretion.
@ast
Evolution of the Sabin strain ...... day period of virus excretion.
@en
P2093
P2860
P1433
P1476
Evolution of the Sabin strain ...... -day period of virus excretion
@en
P2093
P2860
P304
P356
10.1128/JVI.74.7.3001-3010.2000
P577
2000-04-01T00:00:00Z